Krsnaa Diagnostics Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 9,381,562 (74%) | — | ₹89,500 Cr |
| NII (HNI) | — | 1,876,312 (15%) | — | ₹17,900 Cr |
| Retail | — | 1,250,874 (10%) | — | ₹1,193 Cr |
| Employee | — | 232,288 (2%) | — | ₹222 Cr |
| Σ Total | — | 12,741,036 (100%) | — | ₹1,215,495 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹14,310 |
| Retail (Max) | 13 | 195 | ₹186,030 |
| S-HNI (Min) | 14 | 210 | ₹200,340 |
| B-HNI (Min) | 67 | 1,005 | ₹958,770 |
Financial Statements Amount in Crore
| Metric | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Revenue | 661 | 271 | 214 |
| Profit After Tax | 185 | 112 | 58 |
| Total Assets | 605 | 630 | 529 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Proposing to finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra. – 150.81
- 2 Repayment/pre-payment, in full or part, of borrowings from banks and other lenders availed by the Company; and – 146.08
- 3 General corporate purposes – 81.74
Company Overview
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.
The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients.
Competitive Strengths
- Differentiated diagnostic service provider company in India.
- A comprehensive range of diagnostic services i.e. imaging, pathology, etc.
- Strong brand equity with quality healthcare services at affordable prices.
- Extensive market footprint in 13 states across India.
- Consistent financial performance track record.